Wiltrom Valuation

Is 6767 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6767 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6767's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6767's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6767?

Key metric: As 6767 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6767. This is calculated by dividing 6767's market cap by their current revenue.
What is 6767's PS Ratio?
PS Ratio	3x
Sales	NT$312.36m
Market Cap	NT$922.76m

6767 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.8x
Enterprise Value/EBITDA	-36.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 6767's PS Ratio compare to its peers?

The above table shows the PS ratio for 6767 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.4x
4198 S&S Healthcare Holding	2.3x	n/a	NT$769.0m
6847 Puriblood Medical	11.9x	n/a	NT$1.5b
4744 CVC Technologies	0.9x	n/a	NT$1.1b
6730 Lagis Enterprise	2.5x	n/a	NT$1.2b
6767 Wiltrom	3x	n/a	NT$922.8m

Price-To-Sales vs Peers: 6767 is good value based on its Price-To-Sales Ratio (3x) compared to the peer average (4.4x).

Price to Sales Ratio vs Industry

How does 6767's PS Ratio compare vs other companies in the TW Medical Equipment Industry?

2 Companies	Price / Sales	Estimated Growth	Market Cap
4116 BenQ Medical Technology	0.5x	n/a	US$64.60m
4121 Rossmax International	0.4x	n/a	US$43.38m

No more companies available in this PS range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 6767 is expensive based on its Price-To-Sales Ratio (3x) compared to the TW Medical Equipment industry average (2.8x).

Price to Sales Ratio vs Fair Ratio

What is 6767's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6767 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 6767's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Concord Medical

NT$866.7m

Provides hospital management support services primarily in Taiwan.

6518

NT$26.00

3.6%

Universal Vision Biotechnology

NT$17.5b

Operates a chain of eye care clinics in Taiwan and China.

3218

NT$206.50

-2.8%

-28.5%

Hi-Clearance

NT$6.2b

Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan.

1788

NT$138.50

-0.4%

0.4%